Monograph Capital
San Francisco, California, United States · Seed → Series C+
Their stated focus (public profile)
Monograph Capital is a transatlantic life sciences venture firm focused on finding and funding innovative life sciences companies with the goal of translating promising science into life-changing treatments for patients. The firm backs breakthrough therapeutics, diagnostics, and digitally-enabled healthcare across North America and Europe. They combine differentiated sourcing, long-standing pharma relationships, deep medical expertise, and operating experience to create value for company partners and investors.
Stages: Seed → Series C+
Sectors: Life sciences, Medtech, Healthtech
On file: 13 companies on record
Website: monograph.bio
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.